PMHC – eVolve-1 / OZM-060
Trial Description:
A Proof of Concept, Multi-centre, Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on PARP Inhibitor in Ovarian Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Closed to Recruitment
Contact person:
vbowering